# Baxdrostat and Ventricular Remodeling

> **NCT07655362** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Subodh Verma** · enrollment: 286 (estimated)

## Conditions studied

- Cardiac Remodeling

## Interventions

- **DRUG:** Baxdrostat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07655362
- **Lead sponsor:** Subodh Verma
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 286 (ESTIMATED)
- **Last updated:** 2026-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655362, "Baxdrostat and Ventricular Remodeling". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07655362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*